Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
International
Johnson & Johnson Reaches Largest Australian Product-Liability Class…
In September 2022, Johnson & Johnson reached a $204.90 million (A$300 million) settlement in two Australian class action…
Where Are We on State Importation Plans?
In July 2022, Florida Governor Ron DeSantis hinted at potential litigation over the state’s Canadian drug import plan while at a…
Policy and Medicine Compliance Update August 2022 Issue: Focus on 340B…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Italian Sunshine Law Now in Force
On June 26, 2022, the so-called Italian Sunshine Act entered into force, cementing Law n. 62/2022 into law. The law establishes…
FDA Releases Guidance on Prescription Drug Importation
In May 2022, the United States Food and Drug Administration (FDA) issued a Final Guidance, Importation of Prescription Drugs Final…
India’s Device Manufacturers to Receive Their Own Marketing Guidelines
In mid-March 2022, the Department of Pharmaceuticals (DoP) in India published a draft Uniform Code for Medical Device Marketing…
OECD Issues New Bribery Recommendation
On Friday, November 26, 2021, the Organisation for Economic Co-operation and Development (OECD) adopted a new Recommendation for…
PhRMA Files Petition to Stop New Mexico Drug Importation Plan
On March 18, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA), along with the Partnership for Safe Medicines…
States Moving Forward with Canadian Drug Importation Plans, Despite No…
Several states are plowing forward with their efforts to import prescription drugs from Canada to their state, despite no clear…
Canadian Industry Group Attempts to Stymie New Drug Pricing Rules
In mid-December 2020, Reuters reported that the pharmaceutical industry in Canada is trying a last-ditch effort to stop certain…